ask="2.80"
ask_size="2600"
average_daily_volume="129153"
bid="N/A"
bid_size="N/A"
book_value="1.40"
change="+0.08"
change_from_200_day_moving_average="1.64"
change_from_50_day_moving_average="0.98"
change_from_52_week_high="-5.17"
change_From_52_week_low="0.75"
change_in_percent="+3.07%"
close="2.68"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.30"
ebitda="-2.11M"
eps_estimate_current_year="-0.02"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.02"
ex_dividend_date="N/A"
float_shares="2160000"
high="2.71"
high_52_weeks="7.85"
last_trade_date="3/13/2017"
last_trade_price="2.68"
last_trade_size="126"
last_trade_time="3:59pm"
low="2.62"
low_52_weeks="1.93"
market_capitalization="7.18M"
moving_average_200_day="1.04"
moving_average_50_day="1.70"
name="XTL Biopharmaceuticals Ltd."
notes="N/A"
one_year_target_price="6.00"
open="2.62"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+156.53%"
percent_change_from_50_day_moving_average="+57.67%"
percent_change_from_52_week_high="-65.86%"
percent_change_from_52_week_low="+38.86%"
previous_close="2.60"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.86"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="2680000"
short_ratio="0.30"
stock_exchange="NCM"
symbol="XTLB"
volume="42934"
weeks_range_52="1.93 - 7.85"
